Addex Therapeutics (ADXN) Asset Utilization Ratio (2020 - 2025)
Addex Therapeutics (ADXN) posted Asset Utilization Ratio of 0.0 for Q4 2025, down 55.97% sequentially from 0.01 in Q3 2025, and down 86.92% YoY from 0.03 in Q4 2024.
Addex Therapeutics (ADXN) Asset Utilization Ratio (2020 - 2025) Analysis & Trends
Addex Therapeutics has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.0 in Q4 2025.
- Quarterly Asset Utilization Ratio fell 86.92% year-over-year to 0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0 (down 86.92% YoY) and the FY2025 annual result came in at 0.0, down 93.1% from the prior year.
- Asset Utilization Ratio declined to 0.0 in Q4 2025 per ADXN's latest filing, from 0.01 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.35 in Q3 2022 and troughed at 0.0 in Q4 2025.
- A 5-year average of 0.19 and a median of 0.24 in 2021 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio soared 109.99% in 2023, then plunged 88.08% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 0.28 in 2021, then slumped by 50.16% to 0.14 in 2022, then jumped by 109.99% to 0.29 in 2023, then plunged by 88.08% to 0.03 in 2024, then tumbled by 86.92% to 0.0 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.0, 0.01, and 0.02 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.02 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.10 |
| Mar 31, 2024 | 0.33 |
| Dec 31, 2023 | 0.29 |
| Sep 30, 2023 | 0.26 |
| Jun 30, 2023 | 0.26 |
| Mar 31, 2023 | 0.21 |
| Dec 31, 2022 | 0.14 |
| Sep 30, 2022 | 0.35 |
| Jun 30, 2022 | 0.30 |
| Mar 31, 2022 | 0.25 |
| Dec 31, 2021 | 0.28 |
| Sep 30, 2021 | 0.33 |
| Jun 30, 2021 | 0.24 |
| Mar 31, 2021 | 0.24 |
| Dec 31, 2020 | 0.28 |